Evidence map›Paper›PMID 39550627›Full record

ArticleCancer2025

Frequency and clinical associations of common mental disorders in adults with high-grade glioma-A multicenter study.

Susanne Singer, Melanie Schranz, Melina Hippler, Robert Kuchen, Carolin Weiß Lucas, Jürgen Meixensberger, Michael Karl Fehrenbach, Naureen Keric, Meike Mitsdoerffer, Jens Gempt and 12 more

Abstract readMulticenter Study
In one paragraph

Article in Cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Susanne SingerInstitute of Medical Biostatistics, Epidemiology, and Informatics, University Medical Center, Mainz, Germany.ORCID https://orcid.org/0000-0001-5784-7964
Melanie SchranzInstitute of Medical Biostatistics, Epidemiology, and Informatics, University Medical Center, Mainz, Germany.ORCID https://orcid.org/0000-0003-4476-0020
Melina HipplerDepartment of Neurology and Interdisciplinary Neuro-Oncology, University Hospital Tübingen, Hertie Institute for Clinical Brain Research, Eberhard Karls University, Tubingen, Germany.
Robert KuchenInstitute of Medical Biostatistics, Epidemiology, and Informatics, University Medical Center, Mainz, Germany.ORCID https://orcid.org/0000-0003-4384-7511
Carolin Weiß LucasCenter for Neurosurgery, University Hospital Cologne, Faculty of Medicine, University of Cologne, Cologne, Germany.ORCID https://orcid.org/0000-0001-6463-0034
Jürgen MeixensbergerDepartment of Neurosurgery, University Hospital, Leipzig, Germany.ORCID https://orcid.org/0000-0002-1385-8255
Michael Karl FehrenbachDepartment of Neurosurgery, University Hospital, Leipzig, Germany.ORCID https://orcid.org/0000-0001-8396-7740
Naureen KericDepartment of Neurosurgery, University Medical Center, Mainz, Germany.ORCID https://orcid.org/0000-0001-8457-0059
Meike MitsdoerfferDepartment of Neurology, Klinikum Rechts der Isar, Technical University, Munich, Germany.ORCID https://orcid.org/0000-0002-5260-9956
Jens GemptDepartment of Neurosurgery, Klinikum Rechts der Isar, Technical University, Munich, Germany.ORCID https://orcid.org/0000-0003-4123-4690
Jan CoburgerDepartment of Neurosurgery, University Hospital, Ulm, Germany.ORCID https://orcid.org/0000-0002-3677-8258
Almuth Friederike KesslerDepartment of Neurosurgery, University Hospital, Wurzburg, Germany.ORCID https://orcid.org/0000-0002-0605-7791
Jens WehingerDepartment of Neurology, Hospital Ludwigsburg, Ludwigsburg, Germany.
Martin MischDepartment of Neurosurgery, Charité-Universitätsmedizin, Berlin, Germany.ORCID https://orcid.org/0000-0001-5283-5753
Julia OnkenDepartment of Neurology, Charité-Universitätsmedizin, Berlin, Germany.ORCID https://orcid.org/0000-0002-2859-4395
Marion RappDepartment of Neurosurgery, University Hospital, Dusseldorf, Germany.ORCID https://orcid.org/0000-0003-2343-244X
Martin VoßDr Senckenbergisches Institut für Neuroonkologie, University Hospital, Frankfurt, Germany.ORCID https://orcid.org/0000-0001-8469-8204
Minou Nadji-OhlDepartment of Neurosurgery, Katharinenhospital, Klinikum, Stuttgart, Germany.ORCID https://orcid.org/0000-0003-1891-7389
Marcus MehlitzDepartment of Neurosurgery and Pediatric Neurosurgery, Krankenhaus der Barmherzigen Brüder, Trier, Germany.ORCID https://orcid.org/0000-0003-0017-9066
Marcos TatagibaDepartment of Neurosurgery, University Hospital, Tubingen, Germany.ORCID https://orcid.org/0000-0002-1627-9937
Ghazaleh TabatabaiDepartment of Neurology and Interdisciplinary Neuro-Oncology, University Hospital Tübingen, Hertie Institute for Clinical Brain Research, Eberhard Karls University, Tubingen, Germany.ORCID https://orcid.org/0000-0002-3542-8782
Mirjam RenovanzDepartment of Neurology and Interdisciplinary Neuro-Oncology, University Hospital Tübingen, Hertie Institute for Clinical Brain Research, Eberhard Karls University, Tubingen, Germany.ORCID https://orcid.org/0000-0002-2824-3720

Funding

Innovation Fund 01VSF18011
6 · The paper itself

Abstract

backgroundOne third of adults with cancer suffer from common mental disorders in addition to their malignant disease. However, it is unknown whether this proportion is the same in patients who have brain tumors and which factors modulate the risk for psychiatric comorbidity.

methodsIn a multicenter study, patients with high-grade glioma at 13 neurooncology clinics were enrolled consecutively and interviewed with the Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders (SCID) to diagnose common mental disorders. Predictors of psychiatric comorbidity were investigated using binary logistic regression.

resultsSix hundred ninety-one patients were interviewed. The proportion of patients who had mental disorders was 31% (95% confidence interval [CI], 28%-35%). There was evidence for an association of psychiatric comorbidity with the following factors: younger age (odds ratio [OR], 1.9; 95% CI, 1.1-3.4; p = .04), stable disease versus complete remission (OR, 1.7; 95% CI, 1.1-2.8; p = .04), lower income (OR, 1.7; 95% CI, 1.0-2.8; p = .04), living alone (OR, 1.6; 95% CI, 1.0-2.6; p = .05), fatigue (OR, 1.6; 95% CI, 1.1-2.4; p = .03), and impaired cognitive functioning (OR, 2.3; 95% CI, 1.5-3.6; p < .01). There was no evidence for independent effects of gender, histology, affected lobe, time since diagnosis, or employment status.

conclusionsApproximately one third of adult patients with high-grade glioma may suffer from a clinically relevant common mental disorder, without notable disparity between the genders. In particular, clinicians should pay attention to possible comorbidities for cases in which patients exhibit compromised subjective cognitive function, are younger than 50 years, maintain a state of stable disease, or live alone.

Indexed as

Brain NeoplasmsGliomaMental DisordersAdultAgedComorbidityFemaleHumansMaleMiddle AgedNeoplasm GradingYoung Adultgliomamental healthoncologypsycho‐oncologystructured clinical interviewStructured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders (SCID)

Identifiers

PMID39550627
PMCPMC11694336

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.